CA Stock MarketDetailed Quotes
GWS Xtacy Therapeutics Corp
- 0.045
- 0.0000.00%
15min DelayMarket Closed Sep 25 16:00 ET
2.21MMarket Cap-2250P/E (TTM)
0.000High0.000Low0Volume0.000Open0.045Pre Close0.00Turnover0.05052wk High0.00%Turnover Ratio49.21MShares0.04552wk Low-0.02EPS TTM1.95MFloat Cap67.500Historical HighLossP/E (Static)43.32MShs Float0.038Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM-3.75P/B1Lot Size--Div YieldTTM
Xtacy Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q3)Jun 30, 2022 | (Q2)Mar 31, 2022 | (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 140.6K | 55.53%-40.6K | 260.99%36K | -333.02%-426.3K | -4,837.37%-312.63K | 0 | -37,671.60%-91.3K | -719.42%-22.36K | -60.19%-98.45K | 40.29%-6.33K |
| Net income from continuing operations | ---362.52K | -146.29%-259.13K | 62.79%-157.6K | 61.81%-1.37M | 65.94%-839.98K | --0 | 69.36%-105.21K | -158.64%-423.54K | -160.65%-3.58M | -107.45%-2.47M |
| Operating gains losses | ---- | ---- | ---- | 96.18%-11.43K | ---- | ---- | ---- | --100K | -978.25%-298.74K | ---- |
| Remuneration paid in stock | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 848.10%3.03M | 835.67%2.54M |
| Other non cashItems | --828.43K | ---- | ---- | 18.16%300.87K | 38.34%-90.1K | --0 | -77.78%50.21K | 183.96%340.75K | 319.90%254.63K | -142.42%-146.12K |
| Change In working capital | ---325.31K | -78.76%13.53K | 589.19%193.6K | 30.50%652.99K | 74.08%628.87K | --0 | -8.19%63.7K | -196.47%-39.58K | 485.06%500.4K | 204.24%361.26K |
| -Change in prepaid assets | ---- | ---- | ---- | ---297.83K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 90.01%950.82K | ---- | ---- | ---- | -196.47%-39.58K | 376.57%500.4K | --361.26K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | --140.6K | 55.53%-40.6K | 260.99%36K | -333.02%-426.3K | -4,837.37%-312.63K | --0 | -37,671.60%-91.3K | -719.42%-22.36K | -60.19%-98.45K | 40.29%-6.33K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -140.6K | 424.75%40.6K | -132.01%-36K | 233.68%400.67K | 300.72K | 0 | -116.66%-12.5K | 112.45K | 120.08K | 0 |
| Net issuance payments of debt | ---- | ---- | ---- | -109.04%-6.78K | ---- | ---- | ---- | ---- | --75.03K | --0 |
| Net common stock issuance | ---- | ---- | ---- | --407.45K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | -132.01%-36K | ---- | ---- | --0 | ---12.5K | --112.45K | --45.05K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---140.6K | 424.75%40.6K | -132.01%-36K | 233.68%400.67K | --300.72K | --0 | -116.66%-12.5K | --112.45K | --120.08K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | --0 | --0 | --0 | 540.86%25.63K | -62.71%11.92K | -84.43%11.92K | 9,011.65%115.72K | 540.86%25.63K | -78.12%4K | 2,698.60%31.96K |
| Current changes in cash | ---- | ---- | ---- | -218.49%-25.63K | -88.20%-11.92K | --0 | -237.91%-103.8K | 3,401.21%90.09K | 251.45%21.63K | -321.63%-6.33K |
| End cash Position | --0 | --0 | --0 | --0 | --0 | -62.71%11.92K | -84.43%11.92K | 9,011.65%115.72K | 540.86%25.63K | 540.86%25.63K |
| Free cash from | --140.6K | 55.53%-40.6K | 260.99%36K | -333.02%-426.3K | -4,837.37%-312.63K | --0 | -37,671.60%-91.3K | -719.42%-22.36K | -60.19%-98.45K | 40.29%-6.33K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data